SEC Form 4 · accession 0001140361-16-078629

Relypsa Inc · RLYP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 1, 2016

Accepted (ET)

Sep 2, 2016 · 12:37 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001416792

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 1, 2016	U	33,962	$32.00	D	2,250	D
Common Stock	Sep 1, 2016	D	2,250	$32.00	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (Right to Buy)^F2	$4.65	Sep 1, 2016	D	6,976	D	—	Sep 28, 2020	Common Stock	6,976	D
Stock Option (Right to Buy)^F2	$4.65	Sep 1, 2016	D	581	D	—	Nov 29, 2020	Common Stock	581	D
Stock Option (Right to Buy)^F2	$4.65	Sep 1, 2016	D	1,744	D	—	Mar 30, 2021	Common Stock	1,744	D
Stock Option (Right to Buy)^F2	$4.65	Sep 1, 2016	D	872	D	—	Jun 8, 2021	Common Stock	872	D
Stock Option (Right to Buy)^F2	$3.96	Sep 1, 2016	D	15,697	D	—	Sep 13, 2021	Common Stock	15,697	D
Stock Option (Right to Buy)^F2	$3.96	Sep 1, 2016	D	9,011	D	—	Sep 27, 2022	Common Stock	9,011	D
Stock Option (Right to Buy)^F2	$7.40	Sep 1, 2016	D	10,140	D	—	Jul 23, 2023	Common Stock	10,140	D
Stock Option (Right to Buy)^F2	$23.96	Sep 1, 2016	D	3,828	D	—	Jun 18, 2024	Common Stock	3,828	D
Stock Option (Right to Buy)^F3	$35.79	Sep 1, 2016	D	4,500	D	—	Jun 3, 2025	Common Stock	4,500	D
Stock Option (Right to Buy)^F2	$17.00	Sep 1, 2016	D	4,500	D	—	Jun 20, 2026	Common Stock	4,500	D

F1Pursuant to the terms of the Agreement and Plan of Merger, dated as of July 20, 2016 (the "Merger Agreement"), by and among the Issuer, Galencia AG, a public limited company existing under the laws of Switzerland ("Parent"), and Vifor Pharma USA Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent, on September 1, 2016, shares disposed of in exchange for cash consideration of $32.00 per share, without interest, subject to any applicable withholding taxes.
F2Pursuant to the terms of the Merger Agreement, on September 1, 2016, each award of restricted stock units and stock options was cancelled in exchange for the right to receive $32.00 per share in cash less any applicable withholding taxes and in the case of stock options, less the applicable exercise price.
F3Pursuant to the terms of the Merger Agreement, on September 1, 2016, the stock option was cancelled and no cash payment was made as the exercise price exceeded $32.00 per share.